Explore
Validate
Learn3352
antibody from Cell Signaling Technology, Inc
Targeting: STMN1
C1orf215, FLJ32206, Lag, LAP18, OP18, PP17, PP19, PR22, SMN
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 3352 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#3352, RRID:AB_330234
- Product name
- Stathmin Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Simian
- Host
- Rabbit
- Storage
- -20°C
Submitted references Identification and analysis of signaling networks potentially involved in breast carcinoma metastasis to the brain.
STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.
Li F, Glinskii OV, Zhou J, Wilson LS, Barnes S, Anthony DC, Glinsky VV
PloS one 2011;6(7):e21977
PloS one 2011;6(7):e21977
STAT3-stathmin interactions control microtubule dynamics in migrating T-cells.
Verma NK, Dourlat J, Davies AM, Long A, Liu WQ, Garbay C, Kelleher D, Volkov Y
The Journal of biological chemistry 2009 May 1;284(18):12349-62
The Journal of biological chemistry 2009 May 1;284(18):12349-62
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Salvesen HB, Carter SL, Mannelqvist M, Dutt A, Getz G, Stefansson IM, Raeder MB, Sos ML, Engelsen IB, Trovik J, Wik E, Greulich H, Bø TH, Jonassen I, Thomas RK, Zander T, Garraway LA, Oyan AM, Sellers WR, Kalland KH, Meyerson M, Akslen LA, Beroukhim R
Proceedings of the National Academy of Sciences of the United States of America 2009 Mar 24;106(12):4834-9
Proceedings of the National Academy of Sciences of the United States of America 2009 Mar 24;106(12):4834-9
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity.
Saal LH, Johansson P, Holm K, Gruvberger-Saal SK, She QB, Maurer M, Koujak S, Ferrando AA, Malmström P, Memeo L, Isola J, Bendahl PO, Rosen N, Hibshoosh H, Ringnér M, Borg A, Parsons R
Proceedings of the National Academy of Sciences of the United States of America 2007 May 1;104(18):7564-9
Proceedings of the National Academy of Sciences of the United States of America 2007 May 1;104(18):7564-9
PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells.
Liu Z, Lu H, Shi H, Du Y, Yu J, Gu S, Chen X, Liu KJ, Hu CA
Cancer research 2005 Mar 1;65(5):1647-54
Cancer research 2005 Mar 1;65(5):1647-54
No comments: Submit comment
No validations: Submit validation data